BRIEF: BrainAurora opens flat in Hong Kong trading debut

6681.HK

BrainAurora Medical Technology Ltd. (6681.HK) shares opened unchanged in their Hong Kong trading debut on Wednesday, after the company priced the shares at HK$3.22 apiece. The shares continued to trade in a narrow range after that.

The company said it sold approximately 181 million shares in the offering. The Hong Kong portion was oversubscribed by 10.4 times, while the international placement was only fully subscribed.

The company mainly provides cognitive impairment DTx products for hospitals and recorded combined losses of 1.67 billion yuan ($228 million) in the three and a half years from 2021 through the first half of last year. The listing raised net proceeds of about HK$500 million ($64 million), of which approximately 40% will be used for conducting further R&D, and 40% will go to assisting hospitals in establishing new cognitive centers.

By Lau Chi Hang

To subscribe to Bamboo Works weekly free newsletter, click  here

, ,
, ,

Related Articles

RELATED ARTICLES

  1. The provider of digital diagnostics and therapies has linked up with Chinese hospitals to detect conditions such as Alzheimer’s and brain trauma, but the business has yet to turn a profit.
    IPO pitch puts BrainAurora’s earnings under the microscope
  2. BRIEF: Chifeng Gold opens flat in Hong Kong trading debut
    6693.HK
  3. BRIEF: Xiaocaiyuan opens up 5.9% in Hong Kong trading debut
    0999.HK
  4. BRIEF: Dobot opens up 4.8% in Hong Kong trading debut
    2432.HK
  5. BRIEF: EPWK ends flat in Nasdaq trading debut
    EPWK.US
  6. BRIEF: Xunfei Healthcare rises 8% in Hong Kong trading debut  
    2506.HK
  7. BRIEF: ZG Group completes De-SPAC listing, makes Hong Kong trading debut
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Illustration of the rebound of Chinese fintech lenders

A fintech lender rebound, and a hotel mess

Fintech lenders are entering a new golden era, with Jiayin reporting 46% growth for its core consumer lending business in last year's fourth quarter and forecasting similar gains this year. What's driving this rebound? And hotelier H World is still trying to fix a German acquisition from 2019 that wiped out its profit in the fourth quarter of last year. Will the Chinese hotelier be able to turn around this money-losing offshore asset?
JFIN.US HTHT.US